Effects of Protease Inhibitors and Other Commonly Used
Medications as Determined by Drug Interaction Studies
*Dosage Adjustments should be determined by a physician*
Drug Category: ANTIFUNGALS |
||||||
Drug Name | Invirase™ Roche saquinavir |
Recommend | Norvir™ Abbott ritonavir |
Recommend | Crixivan® Merck indinavir |
Recommend |
---|---|---|---|---|---|---|
Fluconazole (Diflucan) | no studies have been conducted - no data available | fluconazole increased ritonavir AUC by 15% | no dosage adjustment necessary | decreases indinavir AUC by19% +/- 33% | no dosage adjustment necessary | |
Ketoconazole (Nizoral) | ketoconazole increased saquinavir AUC and Cmax 3 -fold | no dosage adjustment necessary when ketaconazole 200 mg qd and saquinavir 600 mg tid are given | no studies have been conducted - no data available | ketoconazole increased indinavir AUC levels by 68+/-48% | reduce indinavir to 600 mg q8h |
Drug Category: ANTIMYCOBACTERIALS |
||||||
Drug Name | Invirase™ Roche saquinavir |
Recommend | Norvir™ Abbott ritonavir |
Recommend | Crixivan® Merck indinavir |
Recommend |
---|---|---|---|---|---|---|
Clarithromycin (Biaxin) | no studies have been conducted - no data available | clarithromycin AUC increased by 77% | dosage adjustment to patient with renal impariment is necessary | increased indinavir AUC by 29% +/- 42% and increased clarithromycin AUC by 53% +/- 36% | no dosage adjustment necessary | |
Rifabutin (Mycobutin) | rifabutin decreased saquinavir levels by 40% | if rifabutin therapy is warranted, consider alternative drugs | rifabutin AUC increased by 4 fold rifabutin metabolite (25-0-desacetyl) AUC increased by 35 fold |
coadministration of ritonavir and rifabutin is contraindicated | rifabutin AUC increased by 204 +/-142% | reduce rifabutin to half the standard dose |
Rifampin (Rifadin, others) | rifampin decreased saquinavir levels by 80% | rifampin and saquinavir should not be administered concomitantly | rifampin decreased ritonavir levels by 35% | no dosage adjustment necessary | rifampin decreased AUC of saquinavir by approximately 80% | rifampin and indinavir should not be administered concomitantly |
Drug Category: ORAL CONTRACEPTIVES |
|||||
Invirase™ Roche saquinavir |
Recommend | Norvir™ Abbott ritonavir |
Recommend | Crixivan® Merck indinavir |
Recommend |
---|---|---|---|---|---|
no studies have been conducted - no data available | ethinyl estradiol AUC decreased by 40% | dosage increase or alternate contraceptive measures should be considered | Ortho-Novum 1/35 increased ethinyl estradiol 24+/-17% and norethindrone by 26 +/-14% | no dosage adjustment necessary |
Drug Category: OTHER |
|||||
Invirase™ Roche saquinavir |
Recommend | Norvir™ Abbott ritonavir |
Recommend | Crixivan® Merck indinavir |
Recommend |
---|---|---|---|---|---|
ritonavir markedly increased saquinavir plasma levels (see ritonavir) |
safety of this interaction has not been established | desipramine (Norpramin, others) AUC increased by 145% greater than 20-fold increase in saquinavir AUC theophylline (Theo-Dur, others) AUC decreased by 43% tobacco decreased ritonavir AUC by 18% |
dosage reduction should be considered safety of this interaction has not been established dosage increase may be required |
grapefruit juice decreased indinavir levels by 26% |
Go to the HIVpositive.us Main Menu
39